Wills Eye Institute
Welcome,         Profile    Billing    Logout  
 21 Trials 
26 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Moster, Marlene R
NCT03675412: Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting
N/A
80
US
Caffeine tablet
Wills Eye
Glaucoma, Primary Open Angle
12/25
12/25
NCT05325996: Evaluating Home Testing Devices for the Management of Glaucoma

Recruiting
N/A
50
US
Standard Automatic Perimetry Humphrey Field Analyzer, SAP HFA, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT)
Wills Eye
Glaucoma, Open-Angle
12/26
12/26
Myers, Jonathan S
NCT04784234: Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

Recruiting
N/A
100
US
GlaucoCetin, Placebo
Wills Eye, Guardian Health Sciences, Inc.
Primary Open Angle Glaucoma
02/23
12/23
PREPARE-IT, NCT06566976: Prehabilitation and Rehabilitation in PAD

Recruiting
N/A
300
US
Exercise Intervention, Exercise Therapy, VAPAHCS Rehabilitation Core Components
Palo Alto Veterans Institute for Research, Patient-Centered Outcomes Research Institute
Peripheral Arterial Disease
01/27
07/27
NCT03675412: Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting
N/A
80
US
Caffeine tablet
Wills Eye
Glaucoma, Primary Open Angle
12/25
12/25
NCT05325996: Evaluating Home Testing Devices for the Management of Glaucoma

Recruiting
N/A
50
US
Standard Automatic Perimetry Humphrey Field Analyzer, SAP HFA, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT)
Wills Eye
Glaucoma, Open-Angle
12/26
12/26
TREK-PAD, NCT06033924: Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Recruiting
N/A
225
US
Walking Program: Internet-based, Walking Program: Telehealth-based
VA Office of Research and Development
Peripheral Artery Disease
10/27
10/27
Pro, Michael J
NCT03675412: Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting
N/A
80
US
Caffeine tablet
Wills Eye
Glaucoma, Primary Open Angle
12/25
12/25
NCT05325996: Evaluating Home Testing Devices for the Management of Glaucoma

Recruiting
N/A
50
US
Standard Automatic Perimetry Humphrey Field Analyzer, SAP HFA, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT)
Wills Eye
Glaucoma, Open-Angle
12/26
12/26
Katz, L Jay
NCT05325996: Evaluating Home Testing Devices for the Management of Glaucoma

Recruiting
N/A
50
US
Standard Automatic Perimetry Humphrey Field Analyzer, SAP HFA, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT)
Wills Eye
Glaucoma, Open-Angle
12/26
12/26
Hsu, Jason
NCT05660447: A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Active, not recruiting
2/3
80
US
Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Rhopressa, Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud, Geri-Care Artificial Tears
Wills Eye
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy
12/24
01/25
NCT05030220: Testosterone Levels and Cutibacterium

Recruiting
N/A
300
US
University of Washington
Arthroplasty, Replacement, Shoulder
01/25
01/27
NCT06464770: Optimizing Infection Prophylaxis Prior to Shoulder Surgery

Not yet recruiting
N/A
40
US
Chlorhexidine Gluconate
University of Washington
Arthroplasty Shoulder, Periprosthetic Joint Infection
12/26
12/27
Fudemberg, Scott J
NCT03675412: Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting
N/A
80
US
Caffeine tablet
Wills Eye
Glaucoma, Primary Open Angle
12/25
12/25
Ayres, Brandon
NCT05254587: Accuracy of IOLMASTER 700 Total Keratometry (TK)

Completed
N/A
155
US
IOLMASTER 700 TK
Advanced Vision Care, Clinical Research Consultants, Inc.
Myopia, Hyperopia, Cataract
01/24
01/24
NCT01860612: Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

Recruiting
N/A
500
US
Artificial Iris (CustomFlex)
Clinical Research Consultants, Inc., HumanOptics AG
Full Aniridia, Partial Aniridia
12/25
12/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study

Recruiting
N/A
435
US
AcuFocus, Inc.
Cataract, Presbyopia, Posterior Capsule Opacification
09/27
09/27
Levin, Alex V
NCT06319872: The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients with Retinal Degeneration

Not yet recruiting
1
10
US
Oral disulfiram, Antabuse
University of Rochester
Alcohol Use Disorder, Retinal Dystrophies, Age-Related Macular Degeneration, Retinitis Pigmentosa, Stargardt Disease
04/25
04/25
Regillo, Carl
NCT05409235: Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Completed
2
225
US
OTT166, nesvategrast, Vehicle control
OcuTerra Therapeutics, Inc., Parexel
Diabetic Retinopathy
12/23
12/23
Moster, Mark L
THRIVE, NCT05176639: A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants with Thyroid Eye Disease (TED) ( )

Active, not recruiting
3
154
Europe, Canada, US, RoW
Veligrotug (VRDN-001) Phase 1/2 MAD (HV and TED), VRDN-001 Phase 3 Cohort (THRIVE), VRDN-001 Placebo
Viridian Therapeutics, Inc.
Thyroid Eye Disease
07/24
03/25
NCT05293626: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Active, not recruiting
1/2
12
US
NR082 Injection, Injection needle, Syringe
Neurophth Therapeutics Inc
Leber Hereditary Optic Neuropathy (LHON)
07/25
12/29
Formoso, Michele
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Active, not recruiting
2/3
75
US
Valeda Light Delivery System
LumiThera, Inc., National Eye Institute (NEI)
Dry Age-related Macular Degeneration
05/25
06/25
Toti, Gwen
NCT05254587: Accuracy of IOLMASTER 700 Total Keratometry (TK)

Completed
N/A
155
US
IOLMASTER 700 TK
Advanced Vision Care, Clinical Research Consultants, Inc.
Myopia, Hyperopia, Cataract
01/24
01/24
NCT01860612: Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

Recruiting
N/A
500
US
Artificial Iris (CustomFlex)
Clinical Research Consultants, Inc., HumanOptics AG
Full Aniridia, Partial Aniridia
12/25
12/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26

Download Options